Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

被引:551
作者
Albert, Nathalie L. [1 ]
Weller, Michael [2 ]
Suchorska, Bogdana [3 ]
Galldiks, Norbert [4 ,5 ]
Soffietti, Riccardo [6 ]
Kim, Michelle M. [7 ]
La Fougere, Christian [8 ]
Pope, Whitney [9 ]
Law, Ian [10 ]
Arbizu, Javier [11 ]
Chamberlain, Marc C. [12 ]
Vogelbaum, Michael [13 ]
Ellingson, Ben M. [14 ]
Tonn, Joerg C. [3 ]
机构
[1] Univ Munich, Dept Nucl Med, Munich, Germany
[2] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland
[3] Univ Munich, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany
[4] Res Ctr Juelich, Inst Neurosci & Med, Julich, Germany
[5] Univ Cologne, Dept Neurol, Cologne, Germany
[6] Univ Turin, Dept Neurooncol, Turin, Italy
[7] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[8] Univ Tubingen, Dept Radiol, Div Nucl Med & Clin Mol Imaging, Tubingen, Germany
[9] Univ Calif Los Angeles, Radiol Sci, Los Angeles, CA USA
[10] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark
[11] Univ Navarra, Univ Navarra Clin, Dept Nucl Med, Pamplona, Spain
[12] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[13] Cleveland Clin, Brain Tumor & Neurooncol Ctr, Dept Neurol Surg, Cleveland, OH 44106 USA
[14] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA
关键词
amino acid PET; glioma; guideline; PET imaging; recommendations; POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMAS; DYNAMIC F-18-FET PET; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; RECURRENT MALIGNANT GLIOMA; DUAL-TIME-POINT; BRAIN-TUMORS; C-11-METHIONINE PET; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; FET-PET;
D O I
10.1093/neuonc/now058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose (F-18-FDG) and amino acid tracers (C-11-MET, F-18-FET, and (18) F-FDOPA). An increasing number of studies have been published on PET imaging in the setting of diagnosis, biopsy, and resection as well radiotherapy planning, treatment monitoring, and response assessment. Recommendations are based on evidence generated from studies which validated PET findings by histology or clinical course. This guideline emphasizes the clinical value of PET imaging with superiority of amino acid PET over glucose PET and provides a framework for the use of PET to assist in the management of patients with gliomas.
引用
收藏
页码:1199 / 1208
页数:10
相关论文
共 120 条
[1]   Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: patterns of integration in therapy planning [J].
Arbizu, Javier ;
Tejada, S. ;
Marti-Climent, J. M. ;
Diez-Valle, R. ;
Prieto, E. ;
Quincoces, G. ;
Vigil, C. ;
Idoate, M. A. ;
Zubieta, J. L. ;
Penuelas, I. ;
Richter, J. A. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (05) :771-781
[2]   Brain tumour imaging with PET:: a comparison between [18F]fluorodopa and [11C]methionine [J].
Becherer, A ;
Karanikas, G ;
Szabó, M ;
Zettinig, G ;
Asenbaum, S ;
Marosi, C ;
Henk, C ;
Wunderbaldinger, P ;
Czech, T ;
Wadsak, W ;
Kletter, K .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) :1561-1567
[3]   Pseudoprogression and pseudoresponse in the treatment of gliomas [J].
Brandsma, Dieta ;
van den Bent, Martin J. .
CURRENT OPINION IN NEUROLOGY, 2009, 22 (06) :633-638
[4]   Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas [J].
Brandsma, Dieto ;
Stalpers, Lukas ;
Taal, Walter ;
Sminia, Peter ;
van den Bent, Martinj .
LANCET ONCOLOGY, 2008, 9 (05) :453-461
[5]   Cranial neuronavigation with direct integration of 11C methionine positron emission tomography (PET) data -: Results of a pilot study in 32 surgical cases [J].
Braun, V ;
Dempf, S ;
Weller, R ;
Reske, SN ;
Schachenmayr, W ;
Richter, HP .
ACTA NEUROCHIRURGICA, 2002, 144 (08) :777-782
[6]   Imaging modalities in high-grade gliomas: Pseudoprogression, recurrence, or necrosis? [J].
Caroline, I. ;
Rosenthal, M. A. .
JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (05) :633-637
[7]  
Chao ST, 2001, INT J CANCER, V96, P191, DOI 10.1002/ijc.1016.abs
[8]   Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy [J].
Charnley, Natalie ;
West, Catharine M. ;
Barnett, Carolyn M. ;
Brock, Catherine ;
Bydder, Graeme M. ;
Glaser, Mark ;
Newlands, Ed S. ;
Swindell, Ric ;
Matthews, Julian ;
Price, Pat .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (02) :331-338
[9]  
Chen W, 2005, J NUCL MED, V46, P945
[10]  
Chen W, 2006, J NUCL MED, V47, P904